INTRODUCTION
The amniotic fluid index (AFI), as measured by the four-quadrant ultrasonic technique was added to antepartum testing to better identify fetuses at higher risk of poor perinatal outcome. 1 Oligohydramnios, or decreased amniotic fluid, has since been correlated with increased risk of intrauterine growth restriction, 2, 3 congenital abnormalities, postdates pregnancy, 4 ,5 meconium passage, 6 abnormal fetal heart rate patterns, and lower Apgar scores 7 in multiple studies. Comparisons of the initial studies were marred by the lack of a consistent definition of oligohydramnios, and a variation in the technique of measurement. In 1987, Phelan et al. 8 described a four-quadrant method of assessing AFI. Using that technique, an AFI of 5.0 cm or less is defined as oligohydramnios (value corresponds to less than first percentile at 37 to 43 weeks of gestation). Multiple studies since then have reported increased perinatal morbidity for fetuses with oligohydramnios. Rutherford et al. 7 found an inverse relationship between the AFI and nonreactive nonstress tests, FHR decelerations, meconium staining, cesarean section for fetal distress, and low Apgar scores. Antepartum fetal heart rate decelerations have also been associated with oligohydramnios although Grubb and Paul 9 found no significant increase in intervention for fetal distress (either cesarean or operative vaginal delivery) in the group of gravidae with AFIs of 2.0 to 4.9 cm when compared to those with values of 5.0 cm or more. Other authors have investigated the use of an intrapartum AFI of 5.0 cm or less as a predictor of fetal risk with differing results. Sarno et al. 10 found that intrapartum oligohydramnios was associated with an increased risk of cesarean section for fetal distress, an Apgar score less than 7 at 1 minute and abnormal fetal heart rate patterns. Chauhan et al., 11, 12 however, did not find an increased risk for cesarean for fetal distress or low Apgar scores in patients with intrapartum oligohydramnios. These findings suggest that oligohydramnios as defined by Phelan may not be the optimal choice for use in prediction of increased fetal risk. We sought to determine if an antepartum AFI of 5.0 cm or less is a predictor of adverse perinatal outcome and to determine a threshold level of AFI that could predict adverse outcome by retrospectively reviewing the records of a large antepartum testing service over the course of 1 year.
MATERIALS AND METHODS
The antepartum testing records of 953 women seen over a 12-month period were reviewed. Of these, 779 met the inclusion criteria
OBJECTIVE:
To determine whether an antepartum amniotic fluid index ( AFI ) of 5.0 cm or less is a predictor of adverse perinatal outcome.
STUDY DESIGN:
The antepartum testing records of 779 women seen over a 12 -month period were reviewed. Data, including the reasons for testing, the testing results, and pregnancy outcome were abstracted from these records. Inclusion criteria included a nonanomalous fetus and delivery within 7 days of the last antepartum surveillance test ( modified biophysical profile ). Chi -square analysis, Fisher's exact test, t tests and receiver -operator curves ( ROCs ) were used for analysis.
RESULTS:
An AFI of 5.0 cm or less was significantly associated with an abnormal antepartum fetal heart rate ( FHR ) tracing but not with cesarean delivery, meconium -stained fluid, Apgars less than 7, or NICU admission. Subjects with an AFI of 5.0 cm or less had a higher rate of cesarean for fetal distress, but this did not reach statistical significance. ROCs produced no diagnostic cutoff values for AFI or largest pocket and prediction of any of the chosen parameters.
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including (1) delivery within 7 days of the last antepartum test, (2) delivery at the study institution, (3) nonanomalous fetus, and (4) intact membranes at the time of antepartum testing. Of the patients meeting the criteria 676 (87%) had an AFI greater than 5.0 cm and 103 (13%) had an AFI less than or equal to 5.0 cm. Subjects ranged in gestational age from 27 weeks to 43 weeks. All subjects were evaluated in an antepartum testing unit where nonstress testing and four-quadrant AFI measurements (as described by Phelan) were performed. The deepest pocket was abstracted from the four quadrants recorded on the antepartum testing reports. Tests were performed twice weekly by unit protocol. All nonstress tests (NSTs) and AFIs were performed by a team of four nurses. An NST was reactive if two FHR accelerations of 15 beats per minute lasting at least 15 seconds were present within a 10-minute period. An abnormal FHR tracing was defined as the presence of severe variable or late decelerations, or a bradycardia. Subjects who were found to have oligohydramnios defined as an AFI of 5.0 cm or less were admitted for delivery. Nonreactive tests were those not meeting the criteria despite acoustic stimulation after 40 minutes of testing. Nonreactive NSTs were followed by biophysical profile. If the biophysical profile was abnormal (less than 8) a physician was notified. Subjects with abnormal biophysical profiles or abnormal FHR tracings were transferred to the labor and delivery unit. Intervention was based on further evaluation by the house officers in consultation with faculty members. The diagnosis of fetal distress was based on repetitive decelerations (late decelerations or severe variables) or prolonged bradycardia necessitating cesarean delivery. Records were reviewed for the presence of meconium passage, nonreactive NST, abnormal fetal heart tracing, Apgar scores, route of delivery, neonatal intensive care unit admission, and neonatal death. Subjects were characterized as oligohydramnios (AFI of 5.0 cm or less) or normal amniotic fluid (AFI greater than 5.0 cm) based on their AFI at the time of the last antepartum test for purpose of statistical analysis. Data was compared using chi-square analysis, simple regression, Fisher exact test, and t tests where appropriate. Receiver-operator curves (ROCs) were generated for AFI with regards to prediction of the previously defined adverse outcomes. For comparison, ROCs for largest fluid pocket (a technique not standard in our unit but utilized by others) were also generated. The area under the curve (W) and the standard error (se(W)) were calculated and a two-tailed Z test was used for determining statistical significance of the curves. p values less than 0.05 were considered significant. Table 1 shows the characteristics of the study population. There were no significant differences between the AFI greater than 5.0 cm and AFI less than or equal to 5.0 cm groups with regard to maternal age, gestational age at last antepartum test, or gestational age at delivery. The two groups differed significantly with regard to average AFI, largest single fluid pocket, previous AFI, and time elapsed from test to delivery. The most frequent indications for antepartum testing were maternal diabetes (gestational and preexisting), intrauterine growth restriction, postdates pregnancy, borderline AFI, decreased fetal movement, and hypertension (gestational and chronic). The most frequent indications for testing in the normal AFI group were diabetes, borderline AFI, and postdates. In the women found to have oligohydramnios the most frequent indications were borderline AFI (AFI greater than 5 but less than 10), postdates, and decreased fetal movement. There were significant differences between the two groups with regard to the number of patients seen for borderline AFI ( p<0.025) and GDM ( p<0.01). There were no significant differences between the groups with regard to the number of patients seen for the other indications for testing.
RESULTS
Subjects in the oligohydramnios group were significantly more likely to have an abnormal FHR tracing (14.9% vs 5.3%, p<0.005). Similarly, women in the oligohydramnios group also had a significantly higher rate of nonreactive FHR tracings (5.9% vs 0.74%, p<0.001). There was no difference in the rate of cesarean section between the two groups (16.7% and 22.9% for the oligohydramnios and AFI greater than five groups, respectively). However, there was a trend for an increased rate of cesarean for fetal distress in the oligohydramnios group (9.7% vs 5.0%, p=0.06). Of the women delivered by cesarean, those with oligohydramnios were more likely to have fetal distress leading to cesarean (47%) than those with an AFI greater than 5 cm (20%) ( p<0.05). There was no difference between the groups with regard to meconium-stained fluid, 1 minute Apgar less than 7, or 5 minute Apgar less than 7. There was one neonatal death in the AFI >5.0-cm group. There was a significantly higher percentage of NICU admissions in infants in the normal AFI group than in those with oligohydramnios (28.7% vs. 18.8%, p<0.05). This appears to be attributable to the higher percentage of women with diabetes in the normal AFI group as reanalysis of the data with exclusion of the diabetic patients results in no significant difference between the two groups ( p=0.09, admission rates of 25.5% and 17.2%, respectively). (In our institution, infants of diabetic mothers are routinely observed in the NICU after delivery and this may contribute to the higher rate of admission.) The results given for other outcome variables were not changed by reanalysis with exclusion of the diabetic patients. ROCs for both AFI and largest single vertical pocket as predictors of cesarean delivery, cesarean delivery for fetal distress, fetal distress, NICU admission, and Apgars less than 7 at 1 and 5 minutes were calculated. With regard to AFI, there was a statistically significant relationship with cesarean due to distress ( p=0.015) (Figure 1) , and fetal distress ( p=0.02) (Figure 2 ). There was also a statistically significant inverse relationship between AFI and NICU admission ( p<0.001). All other parameters had nonsignificant relationships with AFI (Table 2 ). There were no significant correlations between the largest vertical pocket and any outcome parameters. ROCs are shown in Figures 1 and 2 . From these, it is clear that despite the significant correlations there are no diagnostic cutoff points for AFI or largest vertical pocket for any of the measured parameters. The ROC is a standard statistical test for assessing goodness of fit of a test. Our sample size is adequate to detect an ROC area under the curve of 70% or greater, which is accepted as an indicator of good performance. Sample size calculations done with an of 0.05 show that our sample size gives us a power of greater than 80% for all parameters and AFI. These calculations were done as described by Hanley and McNeil. 13 
DISCUSSION
Measurement of the AFI was added to nonstress testing to improve assessment of antepartum risk. Women with oligohydramnios have been considered at increased risk of perinatal morbidity, and oligohydramnios is often used as an indication for delivery. For example, in our hospital women with borderline AFI (AFI greater than 5 and less than 10) have a two-fold increase in the incidence of adverse perinatal outcome.
14 In our study there was no increased risk for adverse perinatal outcome when diagnosed with oligohydramnios, as measured by NICU admissions, Apgar scores, and meconium passage. Our conclusions are limited by the fact that very few patients in either group had meconium or low APGAR scores. There was also no increase in the overall rate of cesarean birth for these patients despite lack of blinding of physicians to the AFI or reason for delivery. This knowledge could potentially have biased the physicians with regards to FHR tracing interpretation thereby increasing the rate of cesarean for fetal distress. In addition, the greater number of diabetics in the >5 group might be expected to increase the cesarean rate; however, exclusion of diabetics and reanalysis produces the same result. A recent study by Magann et al. 15 also found the AFI and the two-diameter pocket were both poor diagnostic tests for predicting adverse perinatal outcome. They suggested that the definition of oligohydramnios may not be restrictive enough or that ultrasound measurements may not be accurate. It has been shown that ultrasonographic evaluation of AFI poorly correlates with amniotic fluid volume when measured by the dye-dilution technique in several studies. 16 -18 As a result, its poor predictive value for poor perinatal outcome in our study may be reflective of the limitations of sonographic evaluation of AFI.
In our hospital, most patients with oligohydramnios receive amnioinfusion. During the study period, patients admitted with the diagnosis of oligohydramnios received prophylactic as well as therapeutic amnioinfusion for meconium passage and FHR abnormalities. It is possible that this liberal use of amnioinfusion may have resulted in improved outcomes for the oligohydramnios group that was not seen in previous studies. All patients in this study were also in twice weekly APT, which has been shown to improve perinatal outcome. 19 In addition, all patients with oligohydramnios, regardless of APT findings, were admitted for delivery. Intervention at this AFI may preclude the development of measurable perinatal morbidity. Therefore, our results may be explained by the aggressive management at our institution. It is unclear then, whether isolated oligohydramnios, as defined by an AFI less than or equal to 5.0 cm, is a fetal risk factor for appreciable adverse outcome. Despite this, because close observation and antepartum surveillance appears to improve outcome, management of patients with oligohydramnios could perhaps be individualized in cases where postponement of delivery has potential benefits. This may be especially applicable in preterm cases where the risk of immediate delivery may outweigh the risks that may be associated with oligohydramnios. Oligohydramnios is probably the result of an underlying evolving pathology and thus indicates potential jeopardy. Our data cannot determine whether intervention at an AFI of <5 is universally indicated.
In conclusion, antepartum oligohydramnios was not associated with increased perinatal morbidity in our institution as measured by route of delivery, meconium passage, Apgar scores, NICU admission, and neonatal death. Our study was very limited by its retrospective nature, wide diversity of risk factors, and small number of patients with adverse outcomes. In addition, our uniform early intervention for the finding of oligohydramnios certainly makes our results more difficult to interpret. Our results may indicate that oligohydramnios is associated with increased perinatal morbidity, which is assuaged by intervention. Because antepartum oligohydramnios was associated with abnormal and nonreactive FHR tracings, women with this finding warrant antepartum fetal surveillance and possibly delivery. The question of expectant management in women diagnosed preterm needs further investigation. It may be that the ultrasound demonstration of an AFI <5 is a predictor of increased risk which is masked by intervention. A multicenter randomized controlled trial is needed to better define whether there are threshold levels of AFI that can be used to predict adverse perinatal outcome and guide management accordingly.
